FutureGen Industries Corp. (RMANF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
FutureGen Industries Corp. (RMANF) trades at $0.0001. FutureGen Industries Corp. is an investment firm providing capital and strategic advisory services to public and private companies across agriculture, financial services, technology, and health and wellness sectors. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for RMANF: RMANF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RMANF against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RMANF: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →FutureGen Industries Corp. (RMANF) Financial Services Profile
FutureGen Industries Corp. is a Vancouver-based investment firm established in 2007, specializing in capital provision and strategic advisory for public and private entities. Its portfolio spans agriculture, financial services, technology, and health and wellness, operating within the asset management industry with an OTC Other market listing.
What Is the Investment Thesis for RMANF?
FutureGen Industries Corp. operates as an investment firm focused on providing capital and strategic advisory services across diverse sectors including agriculture, financial services, technology, and health and wellness. The investment thesis centers on the potential for significant capital appreciation derived from successful investments in early-stage or distressed entities within these high-growth or critical sectors. Key value drivers include the firm's ability to identify undervalued assets, provide impactful strategic guidance to portfolio companies, and execute successful exits through IPOs or acquisitions. The company's high gross margin of 94.2% suggests efficient revenue generation from its core advisory or investment activities, despite an overall negative profit margin of -10352.5%, which is indicative of its current operational stage or investment phase. Growth catalysts for FutureGen include the successful maturation and realization of returns from its portfolio companies, the ability to attract further capital for its own investment activities, and strategic expansion into new, promising sub-sectors within its existing focus areas. However, the investment carries substantial risks, highlighted by its $0.00B market capitalization, extremely negative profit margin, and an OTC Other listing, which implies limited liquidity and heightened price volatility. The high Beta of 2.66 also indicates significant sensitivity to broader market movements, necessitating close monitoring of its financial filings and funding progress.
Based on FMP financials and quantitative analysis
RMANF Key Highlights
Market Capitalization of $0.00B, indicating the company is either in its very early stages, pre-revenue, or operating as a micro-cap entity with minimal public valuation.
- A deeply negative Profit Margin of -10352.5%, reflecting substantial operational losses relative to revenue, which is common for early-stage investment firms or those undergoing significant development.
- A robust Gross Margin of 94.2%, suggesting strong efficiency in its core revenue-generating activities, such as advisory services or direct investment returns, before accounting for overheads.
- A high Beta of 2.66, indicating that the company's stock price is significantly more volatile than the overall market, consistent with an OTC-listed, early-stage, or distressed entity.
- The absence of a Dividend Yield, which is typical for growth-focused companies or those prioritizing reinvestment of capital rather than shareholder distributions, especially given its current profitability profile.
Who Are RMANF's Competitors?
RMANF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALISR Calisa Acquisition Corp Right | $0.64 | +0.00% | 79 | |
| IDKFF ThreeD Capital Inc. | $0.07 | +13.85% | $6.98M | 70 |
| ALTEX Firsthand Alternative Energy Fund | $12.93 | -1.90% | $8.98M | 82 |
| BCG Binah Capital Group, Inc. | $1.40 | +0.72% | $23.5M | 78 |
| EEA The European Equity Fund, Inc. | $11.15 | -0.59% | $74.7M | 67 |
| HNNA Hennessy Advisors, Inc. | $9.89 | -1.30% | $78.2M | 81 |
| ETHT ProShares - Ultra Ether ETF | $12.57 | +19.94% | $92.2M | 68 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.62 | -0.18% | $127M | 70 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RMANF's Key Strengths?
Specialized sector focus across agriculture, financial services, technology, and health & wellness, allowing for targeted investment strategies.
- Provision of strategic advisory services, adding value beyond just capital infusion to portfolio companies.
- High gross margin of 94.2%, indicating efficient revenue generation from core activities.
- Established in 2007, providing over a decade of operational experience in the investment landscape.
What Are RMANF's Weaknesses?
Extremely negative profit margin of -10352.5%, indicating significant operational losses.
- Market capitalization of $0.00B, suggesting a very early stage, pre-revenue, or distressed financial position.
- OTC Other listing, implying limited liquidity, higher volatility, and less stringent disclosure requirements.
- High Beta of 2.66, indicating significant sensitivity to broader market fluctuations and increased investment risk.
What Could Drive RMANF Stock Higher?
RMANF catalyst: Successful investment exits, such as an initial public offering (IPO) or acquisition of a portfolio company, which could generate significant capital gains.
- Securing new funding rounds for its portfolio companies, validating their growth potential and enhancing FutureGen's investment value.
- Announcement of new strategic investments in high-growth sub-sectors within technology or health and wellness, signaling future revenue streams.
- Continued development and innovation within its existing portfolio, potentially leading to increased valuations and market recognition for its investees.
What Are the Key Risks for RMANF?
Financial-distress signal — its Altman Z-Score of -15.83 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- The extremely negative profit margin of -10352.5% indicates substantial operational losses, raising concerns about long-term financial viability without significant turnaround.
- Limited liquidity and high volatility due to its OTC Other listing and $0.00B market capitalization, making it challenging for investors to trade shares efficiently.
- Inability to secure further funding for its own operations or for its portfolio companies, which could hinder growth and investment capacity.
- Failure of key portfolio investments to generate expected returns, leading to write-downs and further financial losses for FutureGen Industries Corp.
- High beta of 2.66 exposes the company to significant market fluctuations, amplifying losses during broader market downturns.
What Are the Growth Opportunities for RMANF?
- Expansion into Emerging Technology Sub-sectors: The technology sector continues to be a primary driver of innovation and investment. FutureGen Industries Corp. has an opportunity to deepen its focus on specific high-growth technology sub-sectors, such as artificial intelligence, blockchain, cybersecurity, or sustainable tech. The global venture capital investment in technology remains robust, with billions deployed annually. By identifying and nurturing early-stage companies in these areas, FutureGen could achieve substantial returns within a 3-7 year investment horizon, leveraging its strategic advisory to accelerate growth and market penetration.
- Strategic Investments in Health and Wellness Innovation: The health and wellness sector is experiencing significant expansion, driven by demographic shifts, increased health consciousness, and technological advancements in areas like personalized medicine, digital health, and preventative care. This market is projected to continue its strong growth trajectory. FutureGen can capitalize on this by strategically investing in innovative companies offering disruptive solutions in these segments. Successful investments in this sector could yield substantial returns over a 5-10 year period, establishing FutureGen as a key player in this evolving investment landscape.
- Leveraging Agricultural Technology (AgriTech) Advancements: The agriculture sector is undergoing a transformation driven by the need for increased efficiency, sustainability, and food security. AgriTech, encompassing areas like precision farming, biotechnology, and sustainable agriculture practices, presents a vast and growing market. FutureGen has an opportunity to invest in companies developing cutting-edge solutions that address these global challenges. These investments, typically with a 5-8 year horizon, could benefit from increasing public and private sector focus on sustainable food systems, offering significant long-term growth potential.
- Capitalizing on Financial Services Disruption (FinTech): The financial services industry is continuously being reshaped by FinTech innovations, including digital payments, blockchain-based finance, challenger banks, and AI-driven financial advisory. This disruption creates numerous investment opportunities in companies that are modernizing traditional financial services or creating entirely new models. FutureGen can strategically deploy capital into promising FinTech startups, providing them with both funding and strategic guidance to scale. Successful FinTech investments could generate returns within a 3-6 year timeframe, positioning FutureGen at the forefront of financial innovation.
- Successful Exits from Portfolio Companies: For an investment firm, the primary growth driver and value realization mechanism is the successful exit of its portfolio companies. This includes initial public offerings (IPOs), strategic acquisitions by larger corporations, or secondary sales to other investment funds. FutureGen's ability to identify, nurture, and strategically position its investee companies for lucrative exits is paramount. Each successful exit not only generates significant capital gains but also enhances the firm's reputation and attracts further investment capital. The timeline for such exits varies widely but typically ranges from 3 to 10 years post-investment, directly contributing to FutureGen's overall financial performance and growth.
What Opportunities Does RMANF Have?
- Capitalizing on the growth and innovation within its target sectors (technology, health & wellness, agriculture).
- Achieving successful exits (IPOs, acquisitions) from portfolio companies, generating substantial capital gains.
- Attracting additional capital from institutional or private investors to expand its investment capacity.
- Forming strategic partnerships with industry leaders or other investment firms to enhance deal flow and expertise.
What Threats Does RMANF Face?
- Economic downturns or market volatility negatively impacting investment returns and portfolio valuations.
- Intense competition within the asset management industry for attractive investment opportunities.
- Regulatory changes pertaining to OTC markets or investment firms, potentially increasing compliance burdens.
- Inability to secure sufficient funding for its own operations or for its portfolio companies, hindering growth.
What Are RMANF's Competitive Advantages?
- Specialized sector focus across agriculture, financial services, technology, and health & wellness, allowing for deep industry expertise.
- Provision of strategic advisory services alongside capital, offering a more comprehensive value proposition to investee companies.
- Potential for a strong network of industry contacts and relationships within its target sectors, facilitating deal flow and value creation.
- Ability to identify and invest in undervalued or high-potential early-stage/distressed assets that larger, more risk-averse funds might overlook.
What Does RMANF Do?
FutureGen Industries Corp., inaugurated on September 12, 2007, and headquartered in Vancouver, Canada, operates as a specialized investment firm within the asset management industry. The company's core mandate involves providing both capital and strategic advisory services to a diverse portfolio of companies, encompassing both publicly traded and privately held entities. FutureGen's strategic focus is concentrated on critical and evolving sectors, including agriculture, financial services, technology, and health and wellness. This multi-sector approach allows the firm to pursue opportunities across various economic landscapes, aiming to identify and support businesses with high growth potential or those in need of strategic restructuring. As an investment firm, FutureGen Industries Corp. is involved in the deployment of capital through various investment vehicles, which may include equity investments, debt financing, or other structured financial arrangements tailored to the specific needs of its portfolio companies. Beyond capital infusion, the provision of strategic advisory services is a key differentiator, offering management teams guidance on corporate strategy, operational efficiency, market positioning, and potential mergers and acquisitions. This dual approach aims to not only fund but also actively contribute to the growth and value creation within its investee companies. Given its OTC Other listing and a reported market capitalization of $0.00B, FutureGen Industries Corp. is positioned as an entity likely focused on early-stage ventures or distressed assets, where the potential for significant returns is often accompanied by higher inherent risks. The company's operations are geared towards navigating these complex investment landscapes, leveraging its expertise to foster innovation and drive value in its chosen sectors.
What Products and Services Does RMANF Offer?
- Provides capital to both publicly traded and privately held companies.
- Offers strategic advisory services to assist portfolio companies with growth and operational improvements.
- Focuses investments across four key sectors: agriculture, financial services, technology, and health and wellness.
- Identifies and supports early-stage ventures with high growth potential.
- Potentially assists distressed companies with capital and guidance for turnaround situations.
- Aims to generate returns through successful investments and strategic exits from its portfolio companies.
How Does RMANF Make Money?
- Generates returns through capital gains from successful equity investments in portfolio companies, typically realized upon acquisition or IPO.
- Earns advisory fees for providing strategic guidance and consulting services to its investee entities.
- Potentially receives interest income from debt instruments if it provides loan financing to companies.
- Aims to increase the value of its portfolio companies through active management and strategic input, leading to higher valuations upon exit.
What Industry Does RMANF Operate In?
FutureGen Industries Corp. operates within the highly competitive and dynamic asset management industry, specifically focusing on providing capital and strategic advisory services. This sector is characterized by a diverse range of players, including venture capital firms, private equity funds, and specialized boutique investment houses. FutureGen's strategic positioning targets critical sectors such as agriculture, financial services, technology, and health and wellness, which are experiencing significant innovation and growth. The broader market trend shows increasing demand for alternative investments and specialized capital, particularly for early-stage or transformative companies. FutureGen's niche likely involves identifying opportunities that larger, more traditional asset managers might overlook due to size, risk profile, or specific sector expertise. Its ability to navigate the complexities of these sectors and provide tailored strategic guidance is crucial for its competitive standing, especially as it seeks to generate returns from potentially high-risk, high-reward ventures in a fragmented market.
Who Are RMANF's Key Customers?
- Publicly traded companies seeking strategic capital and advisory for growth or restructuring.
- Privately held companies, including startups and mature businesses, requiring growth capital and strategic guidance.
- Early-stage ventures in agriculture, financial services, technology, and health and wellness sectors.
- Distressed entities seeking investment and strategic support for turnaround and revitalization.
Company Profile
FutureGen Industries Corp. operates in the Asset Management industry within the Financial Services sector. It is headquartered in Vancouver, CA. The company is led by CEO Kristian Thorlund. RMANF has traded publicly since 2019.
Key Financial Metrics
Its free cash flow yield is -13.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 13.30 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -32.4%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
FutureGen Industries Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -15.83 places it in the distress zone, a signal of elevated financial risk.
RMANF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specialized sector focus across agriculture, financial services, technology, and health & wellness, allowing for targeted investment strategies.
- Provision of strategic advisory services, adding value beyond just capital infusion to portfolio companies.
- High gross margin of 94.2%, indicating efficient revenue generation from core activities.
- Established in 2007, providing over a decade of operational experience in the investment landscape.
Bear Case
- Extremely negative profit margin of -10352.5%, indicating significant operational losses.
- Market capitalization of $0.00B, suggesting a very early stage, pre-revenue, or distressed financial position.
- OTC Other listing, implying limited liquidity, higher volatility, and less stringent disclosure requirements.
- High Beta of 2.66, indicating significant sensitivity to broader market fluctuations and increased investment risk.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
RMANF Latest News
No recent news available for RMANF.
RMANF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RMANF.
Price Targets
Wall Street price target analysis for RMANF.
RMANF MoonshotScore
What does this score mean?
The MoonshotScore rates RMANF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Kristian Thorlund
Chief Executive Officer
The specific career history, educational background, and previous roles for Kristian Thorlund are not provided in the available source data. As the Chief Executive Officer of FutureGen Industries Corp., Mr. Thorlund is responsible for the overall strategic direction, operational management, and investment decisions of the firm, guiding its focus on capital provision and strategic advisory services across its target sectors.
Track Record: Details regarding Kristian Thorlund's specific achievements, strategic decisions, or company milestones directly attributable to his leadership at FutureGen Industries Corp. are not available in the provided information. His role as CEO would typically involve overseeing investment strategies, managing the firm's portfolio, and navigating the complexities of an OTC-listed entity with a focus on early-stage or distressed investments.
RMANF OTC Market Information
FutureGen Industries Corp. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market, distinct from the more regulated NYSE or NASDAQ exchanges. Unlike companies listed on major exchanges, OTC Other companies are not required to meet minimum financial standards, public float, or corporate governance requirements. This tier is typically home to shell companies, distressed entities, or companies with limited public information, offering minimal transparency. Investors should understand that this tier has significantly fewer disclosure requirements compared to OTCQX or OTCQB, let alone national exchanges, leading to higher inherent risks.
- OTC Tier: OTC Other
- Limited Public Information: The 'Unknown' disclosure status means investors have very little reliable financial or operational data to base decisions on.
- Extreme Price Volatility: Low trading volume and wide bid-ask spreads can lead to unpredictable and sharp price movements.
- Limited Liquidity: Difficulty in buying or selling shares quickly without affecting the market price, posing a significant exit risk.
- Potential for Fraud and Manipulation: Less regulatory oversight on the OTC Other tier increases the risk of fraudulent activities or market manipulation.
- Lack of Analyst Coverage: Minimal or no coverage from financial analysts, making it challenging for investors to find independent research and valuation.
- Verify any available financial statements, even if unaudited, to assess the company's financial position and performance.
- Scrutinize all news releases and corporate announcements for substance and consistency, looking for any signs of active business operations.
- Research the background and track record of the management team, particularly the CEO, for any prior experience or red flags.
- Investigate the actual business operations and investment portfolio to understand how the company generates its gross margin despite overall losses.
- Assess the company's funding status and its ability to secure capital for ongoing operations and future investments.
- Check for any legal or regulatory actions against the company or its management.
- Evaluate the company's website and online presence for professionalism and up-to-date information.
- Consistent, albeit minimal, public filings or disclosures, even if not fully compliant with higher tiers.
- An active and professional corporate website detailing its business model and investment focus.
- Clearly articulated business operations and a verifiable investment portfolio, even if small.
- Any verifiable industry partnerships or affiliations that lend credibility to its operations.
- Evidence of actual capital deployment and strategic advisory services being rendered to identifiable companies.
Common Questions About RMANF (Financial Services)
What is FutureGen Industries Corp.'s investment strategy and focus?
FutureGen Industries Corp. operates as an investment firm specializing in providing capital and strategic advisory services. Its investment strategy is centered on identifying and supporting both publicly traded and privately held companies across four key sectors: agriculture, financial services, technology, and health and wellness.
How does FutureGen Industries Corp.'s OTC Other listing impact investors?
FutureGen Industries Corp.'s listing on the OTC Other tier of the over-the-counter market significantly impacts investors by introducing heightened risks and operational complexities. This tier has the least stringent disclosure requirements, meaning there is often limited or unknown public financial information available, hindering comprehensive due diligence.
Given its negative profit margin, how does FutureGen Industries Corp. sustain its operations?
FutureGen Industries Corp.'s deeply negative profit margin of -10352.5% indicates that the company is currently operating at a significant loss relative to its revenue. For an investment firm, this financial profile could be sustained through various mechanisms, such as drawing on previously raised capital, securing new rounds of funding from private investors, or relying on capital injections from its founders or principal shareholders.
What are the primary challenges FutureGen Industries Corp. faces in the asset management industry?
FutureGen Industries Corp. navigates a highly competitive and complex asset management industry, facing several primary challenges. Intense competition from established venture capital firms, private equity funds, and other specialized investment houses makes identifying and securing attractive investment opportunities difficult.
What are the key factors to evaluate for RMANF?
Evaluate RMANF on fundamentals, analyst consensus, and risk factors. FutureGen Industries Corp. operates as an investment firm focused on providing capital and strategic advisory services across diverse sectors including agriculture, financial services, technology, and health and wellness. Not financial advice.
How frequently does RMANF data refresh on this page?
RMANF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RMANF's recent stock price performance?
FutureGen Industries Corp. (RMANF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized sector focus across agriculture, financial services, technology, and health & wellness, allowing for targeted investment strategies. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RMANF overvalued or undervalued right now?
FutureGen Industries Corp. (RMANF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is heavily reliant on the limited data provided, particularly for financial metrics and the nature of an OTC Other listing.
- Specific details regarding CEO background, investment portfolio, and operational strategies are not available, leading to generalized statements in several sections.
- The 'Unknown' disclosure status for the OTC listing implies significant data gaps that would typically be available for publicly traded companies.